Superior Efficacy of Tenofovir Alafenamide Compared With Entecavir in Reducing Hepatitis B Surface Antigen: A Multicentre Propensity Score‐Matched Study Using Linear Mixed‐Effects Models

Takashi Kumada, Masanori Atsukawa, Norio Itokawa, Taeang Arai, Hidenori Toyoda, Akihito Tsubota, Tsunamasa Watanabe, Makoto Chuma, Kentaro Matsuura, Atsushi Hiraoka, Toshifumi Tada, Koichi Takaguchi, Keizo Kato, Hiroshi Abe, Joji Tani, Toru Ishikawa, Chikara Ogawa, Toru Asano, Tsunekazu Oikawa, Yoshihiro Matsumoto, Tomoyuki Akita, Junko Tanaka

Open source

DOI: 10.1111/apt.70704
Published: 2026-05-04
Container: Alimentary Pharmacology & Therapeutics
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/apt.70704,
  title = {Superior Efficacy of Tenofovir Alafenamide Compared With Entecavir in Reducing Hepatitis B Surface Antigen: A Multicentre Propensity Score‐Matched Study Using Linear Mixed‐Effects Models},
  author = {Takashi Kumada and Masanori Atsukawa and Norio Itokawa and Taeang Arai and Hidenori Toyoda and Akihito Tsubota and Tsunamasa Watanabe and Makoto Chuma and Kentaro Matsuura and Atsushi Hiraoka and Toshifumi Tada and Koichi Takaguchi and Keizo Kato and Hiroshi Abe and Joji Tani and Toru Ishikawa and Chikara Ogawa and Toru Asano and Tsunekazu Oikawa and Yoshihiro Matsumoto and Tomoyuki Akita and Junko Tanaka},
  year = {2026},
  journal = {Alimentary Pharmacology \&amp; Therapeutics},
  doi = {10.1111/apt.70704},
  url = {https://doi.org/10.1111/apt.70704}
}

RIS

TY  - JOUR
TI  - Superior Efficacy of Tenofovir Alafenamide Compared With Entecavir in Reducing Hepatitis B Surface Antigen: A Multicentre Propensity Score‐Matched Study Using Linear Mixed‐Effects Models
AU  - Takashi Kumada
AU  - Masanori Atsukawa
AU  - Norio Itokawa
AU  - Taeang Arai
AU  - Hidenori Toyoda
AU  - Akihito Tsubota
AU  - Tsunamasa Watanabe
AU  - Makoto Chuma
AU  - Kentaro Matsuura
AU  - Atsushi Hiraoka
AU  - Toshifumi Tada
AU  - Koichi Takaguchi
AU  - Keizo Kato
AU  - Hiroshi Abe
AU  - Joji Tani
AU  - Toru Ishikawa
AU  - Chikara Ogawa
AU  - Toru Asano
AU  - Tsunekazu Oikawa
AU  - Yoshihiro Matsumoto
AU  - Tomoyuki Akita
AU  - Junko Tanaka
PY  - 2026
JO  - Alimentary Pharmacology &amp; Therapeutics
DO  - 10.1111/apt.70704
UR  - https://doi.org/10.1111/apt.70704
ER  -

APA

Kumada, T., Atsukawa, M., Itokawa, N., Arai, T., Toyoda, H., Tsubota, A., Watanabe, T., Chuma, M., Matsuura, K., Hiraoka, A., Tada, T., Takaguchi, K., Kato, K., Abe, H., Tani, J., Ishikawa, T., Ogawa, C., Asano, T., Oikawa, T., Matsumoto, Y., Akita, T., & Tanaka, J. (2026). Superior Efficacy of Tenofovir Alafenamide Compared With Entecavir in Reducing Hepatitis B Surface Antigen: A Multicentre Propensity Score‐Matched Study Using Linear Mixed‐Effects Models. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.70704

Source records

crossref · retrieved 2026-09-26T20:16:28.205Z